FDA warns Akina Pharmacy over unsafe production of compounded drugs and sterility risks.
What happened
FDA inspected the facility from November 7, 2022, to December 9, 2022, and found serious deficiencies in how drug products were produced, including conditions that could contaminate products and put patients at risk. FDA issued a Form FDA 483 on December 9, 2022. On December 30, 2022, the company recalled all lots of drug products intended or expected to be sterile within expiry that were produced using a material noted to be for "research use only," due to a lack of sterility assurance.
What FDA found
The firm used a material for product sterilization that was not appropriate for pharmaceutical use.
FDCA section 501(a)(2)(A) (21 U.S.C. § 351(a)(2)(A))The firm did not confirm that water was suitable for its intended use in making non-sterile drug products.
FDCA section 501(a)(2)(A) (21 U.S.C. § 351(a)(2)(A))The areas used for sterile processing had equipment and surfaces that were hard to clean, generated particles, and were visibly dirty.
FDCA section 501(a)(2)(A) (21 U.S.C. § 351(a)(2)(A))FDA found foreign matter in the production area.
FDCA section 501(a)(2)(A) (21 U.S.C. § 351(a)(2)(A))The firm did not perform adequate smoke studies under dynamic conditions to show unidirectional airflow in the sterile processing area, so products intended to be sterile may not be protected from contamination.
FDCA section 501(a)(2)(A) (21 U.S.C. § 351(a)(2)(A))
What FDA wants
Within 15 working days, notify FDA in writing of the specific steps taken to address the violations, including an explanation of each step, documentation, and steps to prevent recurrence; if the matter cannot be fully addressed, state the reason and timeframe. FDA also strongly recommends a comprehensive assessment of operations, especially aseptic processing, with a third-party consultant who has sterile drug processing expertise.
Who should pay attention
- patients and clinics that receive compounded sterile drugs
- pharmacies or health systems that buy compounded products from Akina
- other compounding pharmacies with sterile operations
This is a summary. Read the original letter on fda.gov.